In a filing, Cassava Sciences Inc revealed its Chief Medical Officer Kupiec James William unloaded Company’s shares for reported $15480.0 on Nov 29 ’24. In the deal valued at $3.87 per share,4,000 shares were sold. As a result of this transaction, Kupiec James William now holds 0 shares worth roughly $0.0.
Then, Schoen Eric sold 59,800 shares, generating $230,828 in total proceeds. Upon selling the shares at $3.86, the Chief Financial Officer now owns 11,500 shares.
Before that, Schoen Eric sold 2,000 shares. Cassava Sciences Inc shares valued at $7,640 were divested by the Chief Financial Officer at a price of $3.82 per share. As a result of the transaction, Schoen Eric now holds 0 shares, worth roughly $0.0.
H.C. Wainwright downgraded its Cassava Sciences Inc [SAVA] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who increased its forecast for the stock in early October from “a Neutral” to “a Buy”. H.C. Wainwright also remained covering SAVA and has decreased its forecast on July 01, 2024 with a “Neutral” recommendation from previously “Buy” rating. B. Riley Securities revised its rating on November 16, 2022. It rated SAVA as “a Neutral” which previously was an “a Buy”.
Price Performance Review of SAVA
On Friday, Cassava Sciences Inc [NASDAQ:SAVA] saw its stock jump 5.09% to $2.89. Over the last five days, the stock has gained 11.58%. Cassava Sciences Inc shares have risen nearly 22.46% since the year began. Nevertheless, the stocks have fallen -87.82% over the past one year. While a 52-week high of $42.20 was reached on 01/03/25, a 52-week low of $2.23 was recorded on 01/02/25. SMA at 50 days reached $13.85, while 200 days put it at $20.37.
Levels Of Support And Resistance For SAVA Stock
The 24-hour chart illustrates a support level at 2.74, which if violated will result in even more drops to 2.59. On the upside, there is a resistance level at 3.05. A further resistance level may holdings at 3.21. The Relative Strength Index (RSI) on the 14-day chart is 29.01, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.15, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 20.48%. Stochastics %K at 60.63% indicates the stock is a holding.
How much short interest is there in Cassava Sciences Inc?
A steep rise in short interest was recorded in Cassava Sciences Inc stocks on 2024-12-13, dropping by -0.47 million shares to a total of 17.62 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 18.08 million shares. There was a decline of -2.65%, which implies that there is a negative sentiment for the stock.
